Department of Interventional Cardiology-Cardiovascular Diseases Institute, 700503 Iasi, Romania.
Department of Internal Medicine, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.
Medicina (Kaunas). 2020 Dec 18;56(12):707. doi: 10.3390/medicina56120707.
Coinfection with both SARS-CoV-2 and influenza viruses seems to be a real and severe problem. However, coinfection is far from a simple matter, and cannot be considered having more unfavorable outcomes as a direct consequence. In reality, the aftermath is powerfully nuanced by the presence of risk factors and specific molecular mechanisms. Our objective was to raise awareness around the unpredictable association between COVID-19 pandemics and the upcoming flu season, and make arguments about the need to develop new routine testing protocols for both viruses, at least during the period with an expected high incidence. Our reasoning is built around the various impacts that the whole range of risk groups, common immunological mechanisms, and complex interactions, such as influenza vaccination, will have on patients' prognosis. We show that the more flawed clinical course is due to managing only one of the infections (and, subsequently, neglecting the other condition).
SARS-CoV-2 和流感病毒的合并感染似乎是一个真实而严重的问题。然而,合并感染远非一件简单的事情,也不能直接认为其结果更不利。实际上,风险因素和特定的分子机制的存在使后果变得非常复杂。我们的目的是提高对 COVID-19 大流行和即将到来的流感季节之间不可预测的关联的认识,并就需要制定针对这两种病毒的新常规检测方案提出论据,至少在预计发病率较高的时期是如此。我们的推理是围绕着各种影响构建的,这些影响涉及到所有风险群体、常见的免疫机制以及复杂的相互作用,如流感疫苗接种,这些都将对患者的预后产生影响。我们表明,更糟糕的临床病程是由于只治疗其中一种感染(随后忽视另一种情况)造成的。